Search results
Found 23 matches for
Oxford Traumatic Brain Injury Research Group
The Oxford Traumatic Brain Injury (TBI) Research Group brings together clinicians and scientists across the University of Oxford to advance the understanding, diagnosis, and treatment of TBI.
Neuromusculoskeletal Health and Science Lab
We use a translational and interdisciplinary approach to study the pathophysiology of neuromusculoskeletal conditions with the ultimate goal to improve management for patients.
Diseases of Protein Glycosylation
Glycosylation is one of the most common and poorly understood forms of post-translational modification. Our aim is to understand the biochemical mechanisms underlying protein glycosylation, as well as decipher the roles that they play in health and disease.
Computational Neurology
Our group applies computational models to study changes in motivation, memory and decision-making that occur in neurological disease. We combine behavioural, neuroimaging, and pharmacological experiments to apply mathematical models to clinical problems.
Oxford Centre for Neuroinflammation
We bring together biomedical, analytical and clinical expertise to shed new light on the causes that underpin neurodegenerative diseases.
NeuroMetrology Lab
Developing methods to accurately and objectively measure neurological disorders such as Parkinson’s Disease and Progressive Supranuclear Palsy.
Translational Neuropathology Group
We study why certain neuronal populations are vulnerable to neurodegeneration and whether pathological changes seen in the peripheral tissues mirror or precede what is ultimately seen in the brain, and how this can be used to develop biomarkers.
Emerging Technologies for Analysis of the Brain (ETA) Research Group
The Emerging Technologies for Analysis of the Brain (ETA) Research Group is a multidisciplinary team leveraging emerging technologies across neuropathology, neuroimmunology, neurodegeneration, neuro-oncology, and molecular genetics to drive innovative insights into brain health and diseases.
Models of Brain Decision Networks
Our group uses computer simulations and mathematical analyses to understand the information processing and activity dynamics of brain networks underlying decision making. We use these models to investigate how neural circuits work in the healthy state, how their dynamics deteriorate in neurological disorders, and how their dynamics and information processing may be best restored by treatments.
Autoimmune Neurology Group
Research, diagnostic and testing service of autoantibodies associated with neurological diseases.
Oxford Epilepsy Research Group
We are a forward-looking dynamic group interested in all aspects of clinical and experimental epileptology with an emphasis on clinically relevant research. The Group draws together all relevant disciplines across Oxford University Hospitals and the University of Oxford.
Molecular Neurodegeneration Research Group
Our aim is to understand fundamental biological processes that could inform the development of targeted therapies and innovative biomarkers in neurodegenerative and neurogenetic disorders.
Cognitive Neurology Research Group
We want to understand how - and why - brain function can be disturbed to lead to poor memory and loss of motivation (apathy). Our aim is to develop new treatments for these conditions across a range of neurological disorders.
Neural Injury Group
Our aim is to gain a better understanding of the response of the peripheral nervous system to injury in order to develop strategies to promote peripheral nerve repair and to prevent the development of neuropathic pain. To do this we employ a variety of multi-disciplinary techniques ranging from transgenic models to human psychophysical studies and genetics.
Diagnostic and Advisory Service for Neuromyelitis Optica
Neuromyelitis optica (NMO) is a rare disease causing inflammation in the spinal cord and optic nerves. The NMO service brings together expertise in diagnostics and clinical management to improve outcomes for this often isolated group of patients.
FMRIB Neurodegeneration Group
FMRIB’s Neurodegeneration group comprises clinical and basic neuroscientists across a range of departments and disciplines with a common interest in using neuroimaging to understand normal ageing and disease processes.
Multiple Sclerosis Clinical Trials Unit
The Multiple Sclerosis and Related Disorders Clinical trials unit is a hybrid unit combining the strengths and longstanding research tradition from both Oxford University and Oxford University Hospitals.
Neurodegeneration and Inflammation Research Group
We explore the neuropathology of multiple sclerosis and other inflammatory and neurodegenerative diseases using a multidisciplinary team approach to post-mortem brain and spinal cord tissue. The aim is that the understanding derived from these studies will translate into ideas for improved treatments for living patients.